NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pharming Group N.V (AS: PHARM)

 
PHARM Technical Analysis
4
As on 14th Mar 2025 PHARM STOCK Price closed @ 0.79 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.95 & Strong Sell for SHORT-TERM with Stoploss of 1.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PHARMSTOCK Price

Open 0.84 Change Price %
High 0.85 1 Day -0.05 -5.95
Low 0.77 1 Week -0.02 -2.47
Close 0.79 1 Month -0.08 -9.20
Volume 17277696 1 Year -0.33 -29.46
52 Week High 1.20 | 52 Week Low 0.65
 
AS Netherlands Most Active Stocks
RDSA 22.80 -1.08%
PHARM 0.79 -5.95%
INGA 18.54 1.31%
KPN 3.75 -0.79%
AGN 5.88 1.38%
UMG 25.46 -8.75%
ABN 19.63 3.32%
MT 29.61 3.57%
PRX 43.47 1.83%
AD 33.73 -0.68%
 
AS Netherlands Top Gainers Stocks
SIFG 11.76 6.14%
RAND 42.53 4.47%
RAND 42.53 4.47%
CRBN 20.84 4.46%
ALLFG 5.47 4.39%
URW 51.24 4.19%
URW 51.24 4.19%
ALFEN 13.26 3.76%
MT 29.61 3.57%
MT 29.61 3.57%
 
AS Netherlands Top Losers Stocks
DPA 0.10 -16.67%
DPA 0.10 -16.67%
UMG 25.46 -8.75%
UMG 25.46 -8.75%
PHARM 0.79 -5.95%
PHARM 0.79 -5.95%
LVIDE 0.42 -4.55%
OCI 11.07 -2.89%
OCI 11.07 -2.89%
BGHL 27.40 -2.14%
 
 
PHARM
Daily Charts
PHARM
Intraday Charts
Whats New @
Bazaartrend
PHARM
Free Analysis
 
PHARM Important Levels Intraday
RESISTANCE0.94
RESISTANCE0.89
RESISTANCE0.86
RESISTANCE0.83
SUPPORT0.75
SUPPORT0.72
SUPPORT0.69
SUPPORT0.64
 
PHARM Forecast March 2025
4th UP Forecast1.12
3rd UP Forecast1.01
2nd UP Forecast0.95
1st UP Forecast0.88
1st DOWN Forecast0.7
2nd DOWN Forecast0.63
3rd DOWN Forecast0.57
4th DOWN Forecast0.46
 
PHARM Weekly Forecast
4th UP Forecast0.98
3rd UP Forecast0.92
2nd UP Forecast0.88
1st UP Forecast0.84
1st DOWN Forecast0.74
2nd DOWN Forecast0.70
3rd DOWN Forecast0.66
4th DOWN Forecast0.60
 
PHARM Forecast2025
4th UP Forecast1.89
3rd UP Forecast1.54
2nd UP Forecast1.32
1st UP Forecast1.1
1st DOWN Forecast0.48
2nd DOWN Forecast0.26
3rd DOWN Forecast0.04
4th DOWN Forecast-0.31
 
 
PHARM Other Details
Segment EQ
Market Capital 502752928.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PHARM Address
PHARM
 
PHARM Latest News
 
Your Comments and Response on Pharming Group N.V
 
PHARM Business Profile
Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Address: Darwinweg 24, Leiden, Netherlands, 2333 CR
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service